We are live on
!
Find out more
Axa Portfolio holdings
AUM
$256M
1-Year Est. Return
25.01%
This Fund
S&P 500
This Quarter
Est. Return
-5.85%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$35.2B
AUM Growth
-$3.94B
(-10%)
Cap. Flow
-$1.12B
Cap. Flow
% of AUM
-3.19%
Top 10 Holdings %
Top 10 Hldgs %
20.4%
Holding
1,273
New
111
Increased
414
Reduced
514
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$63.8M |
| 2 |
Align Technology
ALGN
|
+$61.4M |
| 3 |
Stellantis
STLA
|
+$54.4M |
| 4 |
UBS Group
UBS
|
+$49.7M |
| 5 |
Republic Services
RSG
|
+$44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferrari
RACE
|
+$73.1M |
| 2 |
IPG Photonics
IPGP
|
+$62.1M |
| 3 |
Adobe
ADBE
|
+$61.1M |
| 4 |
UnitedHealth
UNH
|
+$56.3M |
| 5 |
Apple
AAPL
|
+$54.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.78% |
| 2 | Healthcare | 17.08% |
| 3 | Financials | 11.22% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Industrials | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Meritage Homes
MTH
$4.77B
| – | – |
-95,600
| Closed | -$5.83M |
|
1177
NewMarket
NEU
$7.25B
| – | – |
-2,600
| Closed | -$891K |
|
|
NSA
1178
DELISTED
National Storage Affiliates Trust
NSA
| – | – |
-67,600
| Closed | -$4.68M |
|
1179
Nucor
NUE
$58.3B
| – | – |
-5,908
| Closed | -$675K |
|
1180
Novavax
NVAX
$1.21B
| – | – |
-24,220
| Closed | -$3.46M |
|
1181
Pebblebrook Hotel Trust
PEB
$2.18B
| – | – |
-11,100
| Closed | -$248K |
|
1182
Primerica
PRI
$10.1B
| – | – |
-55,200
| Closed | -$8.46M |
|
|
RDUS
1183
DELISTED
Radius Recycling
RDUS
| – | – |
-11,800
| Closed | -$613K |
|
1184
Radware
RDWR
$980M
| – | – |
-42,000
| Closed | -$1.75M |
|
1185
RLJ Lodging Trust
RLJ
$1.88B
| – | – |
-255,723
| Closed | -$3.56M |
|
1186
Ross Stores
ROST
$80.9B
| – | – |
-23,458
| Closed | -$2.68M |
|
1187
RPM International
RPM
$13.8B
| – | – |
-2,000
| Closed | -$202K |
|
1188
Comscore
SCOR
$113M
| – | – |
-540
| Closed | -$36K |
|
|
SNBR
1189
DELISTED
Sleep Number
SNBR
| – | – |
-4,300
| Closed | -$329K |
|
1190
Spotify
SPOT
$108B
| – | – |
-1,277
| Closed | -$299K |
|
1191
Stantec
STN
$8.17B
| – | – |
-45,800
| Closed | -$2.58M |
|
1192
Spyre Therapeutics
SYRE
$8.5B
| – | – |
-17,797
| Closed | -$2.11M |
|
1193
Teledyne Technologies
TDY
$29.2B
| – | – |
-7,630
| Closed | -$3.33M |
|
1194
Thomson Reuters
TRI
$46.4B
| – | – |
-19,646
| Closed | -$2.48M |
|
1195
Ultrapar
UGP
$6.67B
| – | – |
-7,800
| Closed | -$21K |
|
|
UMH
1196
UMH Properties
UMH
$1.34B
| – | – |
-138,600
| Closed | -$3.79M |
|
1197
Upbound Group
UPBD
$1.22B
| – | – |
-9,100
| Closed | -$437K |
|
1198
Vale
VALE
$62.3B
| – | – |
-111,624
| Closed | -$1.56M |
|
1199
Vermilion Energy
VET
$1.66B
| – | – |
-111,900
| Closed | -$1.41M |
|
|
VMEO
1200
DELISTED
Vimeo
VMEO
| – | – |
-214,334
| Closed | -$3.85M |
|
Similar funds
PHAM
HFRG
EBWM
GCCM
CIA
KAM
ACM
CCA
Axa's Q1 2022 Portfolio in Review
As of Q1 2022, Axa held 1,273 positions worth $35.2B, down 10% from $39.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Axa withdrew a net $1.12B in Q1 2022, closing 94 positions and reducing 514 holdings. Its most notable exit was Zai Lab, an estimated $21.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Freshpet worth $30.3M.
- Axa's largest Q1 2022 buy was Freshpet: 294,939 shares worth $30.3M.
- Axa added most to Pfizer in Q1 2022, an estimated $63.8M increase.
- Axa's biggest Q1 2022 reduction was Ferrari, cutting an estimated $73.1M.
- Axa fully exited Zai Lab in Q1 2022, selling an estimated $21.3M.
- Axa's ten largest holdings make up 20% of its $35.2B portfolio in Q1 2022.
- Axa opened 111 new positions and closed 94 in Q1 2022.
- Axa's portfolio value fell 10% quarter-over-quarter to $35.2B.
Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.